Literature DB >> 3747510

Testicular responsiveness to human chorionic gonadotrophin during transient hypogonadotrophic hypogonadism induced by androgenic/anabolic steroids in power athletes.

H Martikainen, M Alén, P Rahkila, R Vihko.   

Abstract

Serum concentrations of testosterone, 17-hydroxyprogesterone, estradiol and several other unconjugated and sulphated steroids were analyzed before and after a single dose of hCG in 6 power athletes, who had used high doses of testosterone and anabolic steroids for 3 months. The study was carried out 3 weeks after cessation of drug use, but the study subjects were still characterized by hypogonadotrophic hypogonadism. The mean concentrations of serum LH and FSH were 2.6 +/- 0.3 and 1.1 +/- 0.03 mIU/ml (mean +/- SEM), respectively, and the concentrations of several precursors and metabolites of testosterone were lower than those before drug use. In contrast, circulating concentrations of steroid sulphates were not decreased, with the exception of dehydroepiandrosterone sulphate. After hCG injection serum testosterone and 5 alpha-dihydrotestosterone concentrations increased significantly, whereas no increases in estradiol and 17-hydroxyprogesterone concentrations were observed. These results demonstrate that during transient hypogonadotrophism in adult men, the testicular responsiveness to a single injection of hCG is similar to that in prepubertal boys without any sign of steroidogenic lesion at the 17,20-desmolase step. Therefore, the appearance of the possibly estradiol-mediated inhibition at the level of C21-steroid side-chain splitting in testosterone biosynthesis seems to be dependent on priming by gonadotrophins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3747510     DOI: 10.1016/0022-4731(86)90288-8

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  11 in total

Review 1.  Andrological aspects of physical exercise and sport medicine.

Authors:  Luigi Di Luigi; Francesco Romanelli; Paolo Sgrò; Andrea Lenzi
Journal:  Endocrine       Date:  2012-03-20       Impact factor: 3.633

Review 2.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

Review 3.  Anabolic-androgenic steroid effects on endocrinology and lipid metabolism in athletes.

Authors:  M Alén; P Rahkila
Journal:  Sports Med       Date:  1988-12       Impact factor: 11.136

4.  Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.

Authors:  Gen Kanayama; James I Hudson; James DeLuca; Stephanie Isaacs; Aaron Baggish; Rory Weiner; Shalender Bhasin; Harrison G Pope
Journal:  Addiction       Date:  2015-02-25       Impact factor: 6.526

Review 5.  Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.

Authors:  Maria A Christou; Panagiota A Christou; Georgios Markozannes; Agathocles Tsatsoulis; George Mastorakos; Stelios Tigas
Journal:  Sports Med       Date:  2017-09       Impact factor: 11.136

6.  Anabolic steroid induced hypogonadism treated with human chorionic gonadotropin.

Authors:  G V Gill
Journal:  Postgrad Med J       Date:  1998-01       Impact factor: 2.401

Review 7.  Effects of androgenic-anabolic steroids in athletes.

Authors:  Fred Hartgens; Harm Kuipers
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 8.  Blood hormones as markers of training stress and overtraining.

Authors:  A Urhausen; H Gabriel; W Kindermann
Journal:  Sports Med       Date:  1995-10       Impact factor: 11.136

Review 9.  Human chorionic gonadotrophin and sport.

Authors:  A T Kicman; R V Brooks; D A Cowan
Journal:  Br J Sports Med       Date:  1991-06       Impact factor: 13.800

10.  Men regret anabolic steroid use due to a lack of comprehension regarding the consequences on future fertility.

Authors:  J R Kovac; J Scovell; R Ramasamy; S Rajanahally; R M Coward; R P Smith; L I Lipshultz
Journal:  Andrologia       Date:  2014-09-15       Impact factor: 2.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.